Search research articles
Contact Us
Filters
Showing results (31-40 of 99) with videos related to
Page
of 10
Sort By:
American Journal of Therapeutics
|
August 4, 2018
Delayed Onset of Azacitidine-Associated Pneumotitis: A Case Report
Satoko Oka, Kazuo Ono, Masaharu Nohgawa
Clinical Case Reports
|
April 12, 2018
Successful treatment of refractory TAFRO syndrome with elevated vascular endothelial growth factor using thyroxine supplements
Satoko Oka, Kazuo Ono, Masaharu Nohgawa
Pathology Oncology Research : POR
|
November 27, 2019
Clinical Effect of CD25 on the Prognosis of Diffuse Large B Cell Lymphoma with Secondary Central Nervous System Relapse
Satoko Oka, Kazuo Ono, Masaharu Nohgawa
Anti-Cancer Drugs
|
January 15, 2020
Successful treatment with brentuximab vedotin for relapsed and refractory adult T cell leukemia
Satoko Oka, Kazuo Ono, Masaharu Nohgawa
Journal of Clinical Pharmacy and Therapeutics
|
September 19, 2019
Clinical effects of CD45 on the prognosis of extramedullary myeloma relapse
Satoko Oka, Kazuo Ono, Masaharu Nohgawa
Leukemia & Lymphoma
|
March 11, 2017
Myelodysplastic syndrome with concomitant del(5q) and JAK2 V617F mutation transformed to acute myeloid leukemia with an additional chromosomal abnormality after a long-term treatment with lenalidomide
Satoko Oka, Kazuo Ono, Masaharu Nohgawa
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
March 29, 2026
[Hematologic responses with favorable safety in three elderly patients with polycythemia vera treated with ropeginterferon alfa-2b]
Satoko Oka, Yuina Ueda, Takaya Mitsuyoshi, et al.
International Journal of Hematology
|
April 29, 2025
Successful treatment of myeloid blast phase chronic myelogenous leukemia with the JAK2 V617 F mutation by combination therapy with asciminib and ropeginterferon alfa-2b in an elderly patient
Satoko Oka, Yuina Akagi, Takaya Mituyoshi, et al.
Leukemia & Lymphoma
|
December 25, 2025
Reduced dose and shorter duration venetoclax regimens are effective for newly diagnosed acute myeloid leukemia patients not considered fit for intensive treatment
Satoko Oka, Yuina Ueda-Akagi, Takaya Mitsuyoshi, et al.
Internal Medicine (Tokyo, Japan)
|
October 29, 2025
Effective Treatment with Ruxolitinib and Ropeginterferon Alfa-2b for Refractory TAFRO-like Syndrome
Satoko Oka, Yuina Ueda-Akagi, Takaya Mitsuyoshi, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 99) with videos related to
Sort By:
Page
of 10
American Journal of Therapeutics
|
August 4, 2018
Delayed Onset of Azacitidine-Associated Pneumotitis: A Case Report
Satoko Oka, Kazuo Ono, Masaharu Nohgawa
Clinical Case Reports
|
April 12, 2018
Successful treatment of refractory TAFRO syndrome with elevated vascular endothelial growth factor using thyroxine supplements
Satoko Oka, Kazuo Ono, Masaharu Nohgawa
Pathology Oncology Research : POR
|
November 27, 2019
Clinical Effect of CD25 on the Prognosis of Diffuse Large B Cell Lymphoma with Secondary Central Nervous System Relapse
Satoko Oka, Kazuo Ono, Masaharu Nohgawa
Anti-Cancer Drugs
|
January 15, 2020
Successful treatment with brentuximab vedotin for relapsed and refractory adult T cell leukemia
Satoko Oka, Kazuo Ono, Masaharu Nohgawa
Journal of Clinical Pharmacy and Therapeutics
|
September 19, 2019
Clinical effects of CD45 on the prognosis of extramedullary myeloma relapse
Satoko Oka, Kazuo Ono, Masaharu Nohgawa
Leukemia & Lymphoma
|
March 11, 2017
Myelodysplastic syndrome with concomitant del(5q) and JAK2 V617F mutation transformed to acute myeloid leukemia with an additional chromosomal abnormality after a long-term treatment with lenalidomide
Satoko Oka, Kazuo Ono, Masaharu Nohgawa
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
March 29, 2026
[Hematologic responses with favorable safety in three elderly patients with polycythemia vera treated with ropeginterferon alfa-2b]
Satoko Oka, Yuina Ueda, Takaya Mitsuyoshi, et al.
International Journal of Hematology
|
April 29, 2025
Successful treatment of myeloid blast phase chronic myelogenous leukemia with the JAK2 V617 F mutation by combination therapy with asciminib and ropeginterferon alfa-2b in an elderly patient
Satoko Oka, Yuina Akagi, Takaya Mituyoshi, et al.
Leukemia & Lymphoma
|
December 25, 2025
Reduced dose and shorter duration venetoclax regimens are effective for newly diagnosed acute myeloid leukemia patients not considered fit for intensive treatment
Satoko Oka, Yuina Ueda-Akagi, Takaya Mitsuyoshi, et al.
Internal Medicine (Tokyo, Japan)
|
October 29, 2025
Effective Treatment with Ruxolitinib and Ropeginterferon Alfa-2b for Refractory TAFRO-like Syndrome
Satoko Oka, Yuina Ueda-Akagi, Takaya Mitsuyoshi, et al.
Page
of 10